- Home
- PNW vs ICLR Comparison
PNW vs ICLR Comparison
Compare PNW & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNW
- ICLR
- Stock Information
- Founded
- PNW 1985
- ICLR 1990
- Country
- PNW United States
- ICLR Ireland
- Employees
- PNW N/A
- ICLR N/A
- Industry
- PNW Electric Utilities: Central
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- PNW Utilities
- ICLR Health Care
- Exchange
- PNW Nasdaq
- ICLR Nasdaq
- Market Cap
- PNW 10.7B
- ICLR 11.6B
- IPO Year
- PNW N/A
- ICLR 1998
- Fundamental
- Price
- PNW $91.45
- ICLR $150.41
- Analyst Decision
- PNW Buy
- ICLR Buy
- Analyst Count
- PNW 10
- ICLR 12
- Target Price
- PNW $95.00
- ICLR $187.82
- AVG Volume (30 Days)
- PNW 1.3M
- ICLR 1.1M
- Earning Date
- PNW 08-06-2025
- ICLR 07-23-2025
- Dividend Yield
- PNW 3.93%
- ICLR N/A
- EPS Growth
- PNW 8.99
- ICLR 11.53
- EPS
- PNW 4.99
- ICLR 9.19
- Revenue
- PNW $5,205,483,000.00
- ICLR $8,192,621,999.00
- Revenue This Year
- PNW $3.77
- ICLR N/A
- Revenue Next Year
- PNW $5.85
- ICLR $2.10
- P/E Ratio
- PNW $18.23
- ICLR $16.55
- Revenue Growth
- PNW 10.69
- ICLR N/A
- 52 Week Low
- PNW $78.93
- ICLR $125.10
- 52 Week High
- PNW $96.50
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- PNW 54.76
- ICLR 57.67
- Support Level
- PNW $88.90
- ICLR $146.56
- Resistance Level
- PNW $91.66
- ICLR $155.90
- Average True Range (ATR)
- PNW 1.26
- ICLR 4.88
- MACD
- PNW 0.25
- ICLR 0.23
- Stochastic Oscillator
- PNW 78.82
- ICLR 57.80
About PNW Pinnacle West Capital Corporation
Pinnacle West is a holding company whose principal subsidiary is Arizona Public Service, a vertically integrated electric utility serving approximately 1.4 million customers across a 35,000-square-mile territory in central Arizona, including the Phoenix area. APS owns or leases more than 6 gigawatts of power generation capacity, including a 29% ownership stake in one of the largest nuclear plants in the US, Palo Verde. Half of the electricity that APS supplies to customers comes from clean energy sources, including nuclear.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.